Surgical Sphincteroplasty Market

Surgical Sphincteroplasty Market - Overview

The global surgical sphincteroplasty market is projected to witness significant growth from 2021 to 2031 (forecast period). The main aspects expected to drive the global surgical sphincteroplasty market include the increased prevalence of Anal Incontinence (AI), the rising frequency of obstetric injury post-childbirth, and the cost-effectiveness of sphincteroplasty. As per the National Institute of Diabetes and Digestive and Kidney Diseases, anal incontinence (AI) is a chronic illness that impacts one in every three people. Moreover, research indicates that AI affects roughly 15% of women. The risk of Al is increased by factors such as age, pelvic surgery, obstetric trauma, obesity, recurrent diarrhea, and other medical disorders such as stroke and diabetes.

Surgical Sphincteroplasty Market - Competitive Landscape

Prominent players in the global surgical sphincteroplasty market are Medtronic, Novo Surgical, Inc., Pelvalon, Salix Pharmaceutical Inc., McKesson, B. Braun, Hill-Rom Services, Inc, Becton, Dickinson and Company, Surgical Holdings, and Johnson & Johnson.

To widen their overseas footprint, key market players are pursuing market strategies such as alliances, technological advancements, acquisitions, investments, and R&D activities.

For example, Laborie Medical Technologies absorbed Pevalon's non-surgical business Eclipse in October 2021. The section is in charge of marketing its most profitable product, vaginal inserts, which are used to treat female incontinence.

Surgical Sphincteroplasty Market - Trends and Opportunities

Factors such as the rising prevalence of anal incontinency (AI), the increasing incidence of obstetric injury post-childbirth, and the growth in innovative approaches to treat AI are expected to boost the global surgical sphincteroplasty market. Moreover, the expansion of clinical research is likely to propel the global surgical sphincteroplasty market.

Due to the partial anterior breakdown of both the external and internal sphincters induced by lengthy vaginal deliveries, AI is more frequent in women. In such cases, sphincter repair is expected to be the most helpful treatment. Stimulated Graciloplasty, Gluteoplasty, and Sphincteroplasty are surgical treatments that can be used to treat it. Non-surgical treatments involve sacral nerve stimulation such as InterSIM and Tibial Nerve Stimulation and the use of biocompatible bulking agents such as vaginal balloon insert, Solesta, and prosthetic intestinal sphincter.

The non-surgical segment is projected to witness significant growth in the global surgical sphincteroplasty market during the projection period. The segment growth is expected due to factors such as increased use of non-invasive operations by surgeons and caregivers and promising and satisfactory outcomes.

Numerous studies are being conducted in developed countries to discover a better non-invasive means of curing AI, which is anticipated to push the global surgical sphincteroplasty market. However, the COVID-19 pandemic in 2020 interrupted clinical investigations in developed countries. Moreover, patients' fear of virus transmission has resulted in fewer elective procedures and lower hospital admission rates, which had an impact on the worldwide market. Reduced surgical supplies as a result of a standstill in logistics and a shortage of hospital care staff have resulted in a reduction in the surgical sphincteroplasty market. Nevertheless, the global market is projected to expand post-COVID-19 pandemic.

Surgical Sphincteroplasty Market - Regional Landscape

The North America surgical sphincteroplasty market is anticipated to grow during the forecast period due to better healthcare infrastructure and the presence of major industry players. Moreover, an increase in clinical research to identify concrete treatment choices for AI is expected to drive regional market expansion.

The surgical sphincteroplasty market in Asia Pacific is likely to experience growth during the projected period. Factors such as greater acceptance of cost-effective operations such as sphincteroplasty, an aging population, and increased government spending on the healthcare sector are projected to boost the regional market.